Search Results - "Trepel, Jane"
-
1
Structural and functional complexity of HSP90 in cellular homeostasis and disease
Published in Nature reviews. Molecular cell biology (01-11-2023)“…Heat shock protein 90 (HSP90) is a chaperone with vital roles in regulating proteostasis, long recognized for its function in protein folding and maturation. A…”
Get full text
Journal Article -
2
Targeting the dynamic HSP90 complex in cancer
Published in Nature reviews. Cancer (01-08-2010)“…Key Points Heat shock protein 90 (HSP90) is a molecular chaperone of numerous oncoproteins. Therefore, cancer cells can be considered to be 'addicted' to this…”
Get full text
Journal Article -
3
Clinical Evaluation and Biomarker Profiling of Hsp90 Inhibitors
Published in Methods in molecular biology (Clifton, N.J.) (2018)“…Inhibitors of the molecular chaperone heat shock protein 90 (Hsp90) have been in clinical development as anticancer agents since 1998. There have been 18 Hsp90…”
Get more information
Journal Article -
4
Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
Published in Journal of clinical oncology (10-06-2013)“…Entinostat is an oral isoform selective histone deacetylase inhibitor that targets resistance to hormonal therapies in estrogen receptor-positive (ER+) breast…”
Get full text
Journal Article -
5
Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer
Published in Nature communications (23-06-2021)“…Immune checkpoint blockade (ICB) benefits only a small subset of patients with small cell lung cancer (SCLC), yet the mechanisms driving benefit are poorly…”
Get full text
Journal Article -
6
Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development
Published in Cell stress & chaperones (01-07-2018)“…The molecular chaperone Hsp90 is one component of a highly complex and interactive cellular proteostasis network (PN) that participates in protein folding,…”
Get full text
Journal Article -
7
Stressing the Development of Small Molecules Targeting HSP90
Published in Clinical cancer research (15-01-2014)“…Inhibitors of the molecular chaperone HSP90 have been in clinical development as anticancer agents since 1999. Recent clinical studies, including the work of…”
Get full text
Journal Article -
8
Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study
Published in The lancet oncology (01-02-2018)“…High-grade serous ovarian carcinoma is characterised by TP53 mutations, DNA repair defects, and genomic instability. We hypothesised that prexasertib…”
Get full text
Journal Article -
9
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity
Published in Oncotarget (07-02-2017)“…Immunogenic cell death (ICD) is a form of cell death that activates an adaptive immune response against dead-cell-associated antigens. Cancer cells killed via…”
Get full text
Journal Article -
10
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study
Published in Journal of thoracic oncology (01-08-2019)“…Despite high tumor mutationburden, immune checkpoint blockade has limited efficacy in SCLC. We hypothesized that poly (ADP-ribose) polymerase inhibition could…”
Get more information
Journal Article -
11
Threonine 22 Phosphorylation Attenuates Hsp90 Interaction with Cochaperones and Affects Its Chaperone Activity
Published in Molecular cell (18-03-2011)“…Heat shock protein 90 (Hsp90) is an essential molecular chaperone whose activity is regulated not only by cochaperones but also by distinct posttranslational…”
Get full text
Journal Article -
12
A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer
Published in Medical oncology (Northwood, London, England) (01-06-2017)“…Ovarian cancer, which ranks fifth in cancer deaths among women, is the most lethal gynecologic malignancy. Epithelial ovarian cancer (EOC) is the most common…”
Get full text
Journal Article -
13
Temozolomide in the Era of Precision Medicine
Published in Cancer research (Chicago, Ill.) (15-02-2017)“…In the January 1, 2017, issue of , Nagel and colleagues demonstrate the value of assays that determine the DNA repair capacity of cancers in predicting…”
Get full text
Journal Article -
14
Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer
Published in Cancer research (Chicago, Ill.) (15-07-2018)“…Castration-resistant prostate cancer (CRPC) is characterized by reactivation of androgen receptor (AR) signaling, in part by elevated expression of AR splice…”
Get full text
Journal Article -
15
HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
Published in Scientific reports (03-05-2018)“…Heat shock factor 1 (HSF1) initiates a broad transcriptional response to proteotoxic stress while also mediating a cancer-specific transcriptional program…”
Get full text
Journal Article -
16
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
Published in Cancer cell (12-04-2021)“…Small cell neuroendocrine cancers (SCNCs) are recalcitrant cancers arising from diverse primary sites that lack effective treatments. Using chemical genetic…”
Get full text
Journal Article -
17
RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…CellMiner (http://discover.nci.nih.gov/cellminer) and CellMinerCDB (https://discover.nci.nih.gov/cellminercdb/) are web-based applications for mining publicly…”
Get full text
Journal Article -
18
Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 ( SLFN11) Expression with Class I Histone Deacetylase Inhibitors
Published in Clinical cancer research (15-04-2018)“…Schlafen 11 (SLFN11), a putative DNA/RNA helicase is a dominant genomic determinant of response to DNA-damaging agents and is frequently not expressed in…”
Get full text
Journal Article -
19
Asymmetric Hsp90 N Domain SUMOylation Recruits Aha1 and ATP-Competitive Inhibitors
Published in Molecular cell (23-01-2014)“…The stability and activity of numerous signaling proteins in both normal and cancer cells depends on the dimeric molecular chaperone heat shock protein 90…”
Get full text
Journal Article -
20
Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy
Published in Clinical cancer research (15-02-2021)“…New therapies are needed to treat immune checkpoint inhibitor-resistant non-small cell lung cancer (NSCLC) and identify biomarkers to personalize treatment…”
Get full text
Journal Article